ASSERTIO THERAPEUTICS, INC. Gross Profit
ASSERTIO THERAPEUTICS, INC. reported Gross Profit of $28.64 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-11.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2019-03-11
- ASSERTIO THERAPEUTICS, INC. gross profit for the quarter ending 2018-12-31 was $28.64M, a 62.55% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. gross profit for the quarter ending 2018-09-30 was $26.46M, a 65.99% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. gross profit for the quarter ending 2018-06-30 was $24.09M, a 70.08% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. gross profit for the quarter ending 2018-03-31 was $32.31M, a 55.44% decline year-over-year.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2018-12-31 | $28.64M 10-K · filed 2019-03-11 | $55.09M derived: sum of 2 quarters · filed 2019-03-11 | $79.18M derived: sum of 3 quarters · filed 2019-03-11 | $111.49M derived: sum of 4 quarters · filed 2019-03-11 |
| 2018-09-30 | $26.46M 10-K · filed 2019-03-11 | $50.55M derived: sum of 2 quarters · filed 2019-03-11 | $82.86M derived: sum of 3 quarters · filed 2019-03-11 | $159.31M derived: sum of 4 quarters · filed 2019-03-11 |
| 2018-06-30 | $24.09M 10-K · filed 2019-03-11 | $56.40M derived: sum of 2 quarters · filed 2019-03-11 | $132.85M derived: sum of 3 quarters · filed 2019-03-11 | $210.66M derived: sum of 4 quarters · filed 2019-03-11 |
| 2018-03-31 | $32.31M 10-K · filed 2019-03-11 | $108.77M derived: sum of 2 quarters · filed 2019-03-11 | $186.57M derived: sum of 3 quarters · filed 2019-03-11 | $267.08M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-12-31 | $76.45M 10-K · filed 2019-03-11 | $154.26M derived: sum of 2 quarters · filed 2019-03-11 | $234.77M derived: sum of 3 quarters · filed 2019-03-11 | $307.28M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-09-30 | $77.81M 10-K · filed 2019-03-11 | $158.31M derived: sum of 2 quarters · filed 2019-03-11 | $230.83M derived: sum of 3 quarters · filed 2019-03-11 | $331.84M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | $80.51M 10-K · filed 2019-03-11 | $153.02M derived: sum of 2 quarters · filed 2019-03-11 | $254.04M derived: sum of 3 quarters · filed 2019-03-11 | $344.10M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | $72.51M 10-K · filed 2019-03-11 | $173.53M derived: sum of 2 quarters · filed 2019-03-11 | $263.59M derived: sum of 3 quarters · filed 2019-03-11 | $359.14M derived: sum of 4 quarters · filed 2019-03-11 |
| 2016-12-31 | $101.02M 10-K · filed 2018-03-01 | $191.08M derived: sum of 2 quarters · filed 2018-03-01 | $286.63M derived: sum of 3 quarters · filed 2018-03-01 | $367.65M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-09-30 | $90.06M 10-K · filed 2018-03-01 | $185.61M derived: sum of 2 quarters · filed 2018-03-01 | $266.63M derived: sum of 3 quarters · filed 2018-03-01 | $356.69M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $95.55M 10-K · filed 2018-03-01 | $176.57M derived: sum of 2 quarters · filed 2018-03-01 | $266.63M derived: sum of 3 quarters · filed 2018-03-01 | $350.44M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $81.02M 10-K · filed 2018-03-01 | $171.07M derived: sum of 2 quarters · filed 2018-03-01 | $254.89M derived: sum of 3 quarters · filed 2018-03-01 | $326.32M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $90.05M 10-K · filed 2017-02-24 | $173.86M derived: sum of 2 quarters · filed 2017-02-24 | $245.29M derived: sum of 3 quarters · filed 2017-02-24 | $273.85M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-09-30 | $83.81M 10-K · filed 2017-02-24 | $155.24M derived: sum of 2 quarters · filed 2017-02-24 | $183.80M derived: sum of 3 quarters · filed 2017-02-24 | $214.44M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $71.43M 10-K · filed 2017-02-24 | $99.99M derived: sum of 2 quarters · filed 2017-02-24 | $130.63M derived: sum of 3 quarters · filed 2017-02-24 | $157.69M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $28.56M 10-K · filed 2017-02-24 | $59.20M derived: sum of 2 quarters · filed 2017-02-24 | $86.26M derived: sum of 3 quarters · filed 2017-02-24 | $109.83M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $30.64M 10-K · filed 2016-02-26 | $57.70M derived: sum of 2 quarters · filed 2016-02-26 | $81.27M derived: sum of 3 quarters · filed 2016-02-26 | $99.07M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-09-30 | $27.06M 10-K · filed 2016-02-26 | $50.63M derived: sum of 2 quarters · filed 2016-02-26 | $68.44M derived: sum of 3 quarters · filed 2016-02-26 | $85.06M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $23.57M 10-K · filed 2016-02-26 | $41.37M derived: sum of 2 quarters · filed 2016-02-26 | $57.99M derived: sum of 3 quarters · filed 2016-02-26 | $72.52M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $17.80M 10-K · filed 2016-02-26 | $34.42M derived: sum of 2 quarters · filed 2016-02-26 | $48.95M derived: sum of 3 quarters · filed 2016-02-26 | $61.37M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $16.62M 10-K · filed 2015-02-26 | $31.15M derived: sum of 2 quarters · filed 2015-02-26 | $43.57M derived: sum of 3 quarters · filed 2015-02-26 | $51.21M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-09-30 | $14.53M 10-K · filed 2015-02-26 | $26.95M derived: sum of 2 quarters · filed 2015-02-26 | $34.59M derived: sum of 3 quarters · filed 2015-02-26 | $44.76M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $12.42M 10-K · filed 2015-02-26 | $20.06M derived: sum of 2 quarters · filed 2015-02-26 | $30.24M derived: sum of 3 quarters · filed 2015-02-26 | $38.16M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $7.64M 10-K · filed 2015-02-26 | $17.82M derived: sum of 2 quarters · filed 2015-02-26 | $25.74M derived: sum of 3 quarters · filed 2015-02-26 | $27.50M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $10.17M 10-K · filed 2014-03-17 | $18.09M derived: sum of 2 quarters · filed 2014-03-17 | $19.85M derived: sum of 3 quarters · filed 2014-03-17 | $21.44M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-09-30 | $7.92M 10-K · filed 2014-03-17 | $9.68M derived: sum of 2 quarters · filed 2014-03-17 | $11.27M derived: sum of 3 quarters · filed 2014-03-17 | $11.16M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $1.76M 10-K · filed 2014-03-17 | $3.35M derived: sum of 2 quarters · filed 2014-03-17 | $3.24M derived: sum of 3 quarters · filed 2014-03-17 | $11.29M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $1.59M 10-K · filed 2014-03-17 | $1.48M derived: sum of 2 quarters · filed 2014-03-17 | $9.54M derived: sum of 3 quarters · filed 2014-03-17 | $23.55M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | -$111.00K 10-K · filed 2013-02-22 | $7.94M derived: sum of 2 quarters · filed 2013-02-22 | $21.96M derived: sum of 3 quarters · filed 2013-02-22 | $35.63M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-09-30 | $8.05M 10-K · filed 2013-02-22 | $22.07M derived: sum of 2 quarters · filed 2013-02-22 | $35.74M derived: sum of 3 quarters · filed 2013-02-22 | |
| 2011-06-30 | $14.01M 10-K · filed 2013-02-22 | $27.69M derived: sum of 2 quarters · filed 2013-02-22 | ||
| 2011-03-31 | $13.68M 10-K · filed 2013-02-22 |